SHA
ABBV icon

Seneca House Advisors’s AbbVie ABBV Stock Holding History

Seneca House Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$597K Buy
2,371
+104
+5% +$22.4K 0.21% 67
2026
Q1 		$493K Buy
2,267
+63
+3% +$14K 0.2% 71
2025
Q4 		$504K Buy
2,204
+27
+1% +$6.15K 0.19% 69
2025
Q3 		$504K Buy
2,177
+84
+4% +$17.1K 0.2% 59
2025
Q2 		$388K Buy
2,093
+56
+3% +$10.4K 0.17% 61
2025
Q1 		$427K Buy
2,037
+6
+0.3% +$1.17K 0.18% 61
2024
Q4 		$361K Sell
2,031
-56
-3% -$10.3K 0.14% 71
2024
Q3 		$412K Buy
2,087
+47
+2% +$8.77K 0.17% 60
2024
Q2 		$350K Buy
2,040
+34
+2% +$5.63K 0.15% 64
2024
Q1 		$365K Sell
2,006
-5
-0.2% -$862 0.16% 67
2023
Q4 		$312K Sell
2,011
-5
-0.2% -$729 0.14% 64
2023
Q3 		$301K Buy
2,016
+27
+1% +$3.96K 0.16% 64
2023
Q2 		$268K Hold
1,989
– – 0.13% 70
2023
Q1 		$317K Hold
1,989
– – 0.16% 70
2022
Q4 		$321K Hold
1,989
– – 0.18% 70
2022
Q3 		$267K Hold
1,989
– – 0.2% 68
2022
Q2 		$305K Sell
1,989
-1
-0.1% -$153 0.2% 72
2022
Q1 		$323K Hold
1,990
– – 0.17% 72
2021
Q4 		$269K Buy
1,990
+21
+1% +$2.48K 0.14% 75
2021
Q3 		$212K Hold
1,969
– – 0.13% 84
2021
Q2 		$222K Hold
1,969
– – 0.14% 79
2021
Q1 		$213K Buy
1,969
+24
+1% +$2.57K 0.15% 76
2020
Q4 		$208K Buy
+1,945
New +$187K 0.15% 76
2019
Q2 		– Sell
-5,405
Closed -$436K – 91
2019
Q1 		$436K Sell
5,405
-1,287
-19% -$105K 0.38% 64
2018
Q4 		$617K Sell
6,692
-171
-2% -$15K 0.58% 46
2018
Q3 		$649K Buy
6,863
+497
+8% +$47.1K 0.51% 53
2018
Q2 		$590K Buy
6,366
+2,550
+67% +$249K 0.48% 57
2018
Q1 		$361K Buy
3,816
+828
+28% +$91K 0.3% 75
2017
Q4 		$289K Buy
+2,988
New +$282K 0.25% 82

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Seneca House Advisors's ABBV Position: Q2 2026 in Review

Seneca House Advisors increased its AbbVie (ABBV) stake by 4.6% in Q2 2026, buying an estimated $22.4K and bringing the position to 2,371 shares worth $597K. The position accounts for 0.21% of the portfolio, ranked #67.

Seneca House Advisors first reported a position in ABBV in Q4 2017 and has held it in 29 quarters since. The position peaked at $649K in Q3 2018. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Seneca House Advisors held 2,371 shares of AbbVie worth $597K as of Q2 2026.
  • Seneca House Advisors bought 104 AbbVie shares in Q2 2026, an estimated $22.4K.
  • AbbVie made up 0.21% of Seneca House Advisors's portfolio in Q2 2026, its #67 holding.
  • Seneca House Advisors first reported a position in AbbVie in Q4 2017 and has held it in 29 quarters since.
  • Seneca House Advisors's AbbVie position peaked at $649K in Q3 2018.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Seneca House Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.